Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04237012 · ClinicalTrials.gov registry record · Phase 4
ACCURATE Study for Subjects With Dry Eyes
A Phase 4 study of Dry Eye Syndromes, sponsored by The Eye Centers of Racine and Kenosha.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04237012: Completed Phase 4 study of Dry Eye Syndromes, sponsored by The Eye Centers of Racine and Kenosha.
NCT04237012 is a Phase 4 study of Dry Eye Syndromes that has completed, run by The Eye Centers of Racine and Kenosha. The registered enrollment target is 30 participants, below the 413-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04237012, a Phase 4 study of Dry Eye Syndromes, has completed, sponsored by The Eye Centers of Racine and Kenosha.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine treatment and imaging outcomes in bilateral ocular surface disease management with an intracanalicular dexamethasone (0.4 mg) insert compared to standard topical over-the-counter artificial tears lubrication management
Primary Outcome
To determine the effect of dexamethasone insert plus over-the-counter artificial tears prn compared to over the counter artificial tears prn from Baseline at Week 2 (at 8 am, 12 pm and 4 pm) as measured by iTrace and IOL Master 700: and comfort of dry eyes using the OSDI scale and reading scores
Conditions Studied
Interventions
- DRUG Dextenza 0.4Mg Intracanalicular Insert
- OTHER Over the counter Artificial tears
Study Locations (1)
Wisconsin
- The Eye Center of Racine - Racine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2021-12-30 |
| Phase | Phase 4 |
What the finished NCT04237012 record still lists
NCT04237012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 413-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Dry Eye Syndromes appearing as the primary indexed condition, and to 2 interventions - of which Dextenza 0.4Mg Intracanalicular Insert is the first listed.
NCT04237012 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04237012 about?
NCT04237012 is a clinical study titled "ACCURATE Study for Subjects With Dry Eyes". To determine treatment and imaging outcomes in bilateral ocular surface disease management with an intracanalicular dexamethasone (0.4 mg) insert compared to standard topical over-the-counter artificial tears lubrication management
What is the current status of trial NCT04237012?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2019-12-16. Estimated completion is 2021-12-30.
What conditions does trial NCT04237012 study?
This clinical trial studies the following conditions: Dry Eye Syndromes.
What interventions are being tested in trial NCT04237012?
The interventions under investigation include: Dextenza 0.4Mg Intracanalicular Insert (DRUG), Over the counter Artificial tears (OTHER).
Who is sponsoring clinical trial NCT04237012?
This trial is sponsored by The Eye Centers of Racine and Kenosha, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04237012 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04237012's enrollment target sits among peer trials
30 14th of 17 higher than 4 of 17 other Dry Eye Syndromes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye Syndromes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®
COMPLETED · Phase 4
-
Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease
COMPLETED · Phase 4
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
ACTIVE NOT RECRUITING · NA
-
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
COMPLETED · NA
-
TrueTear in Sjogren's Disease Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI